English
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Xiubao Ren

Director of the Center for Immunotherapy Transformation Research and leader of the Department of Immunotherapy Science for Tumors
Chief physician, professor, Doctor of Medicine, Doctoral supervisor
Vice Chairman and Secretary-General of the Clinical Application Professional Committee of Chinese Society of Medical Biotechnology
Association and board member of the Tianjin Anti-cancer Association
Standing member of the Lung cancer Professional Committee and rehabilitation and palliative treatment Professional Committee of Tianjin Anti-cancer Association
Deputy director of Tianjin Lung cancer Diagnosis and Treatment Center

Expert Introduction：

In the clinical and basic research of tumor immunotherapy, significant achievements have been made, especially in organically combining conventional chemotherapy with modern biological treatment technologies (such as tumor vaccine therapy, CIK cell therapy, molecular targeted drug therapy, and allogeneic hematopoietic stem cell transplantation immunotherapy). This has gradually formed a new model of personalized biological tumor therapy characterized by "chemotherapy to eliminate evil, immunotherapy to consolidate the foundation."

12